Literature DB >> 19193741

Schizophrenia as a systemic disease.

Brian Kirkpatrick1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19193741      PMCID： PMC2659316          DOI： 10.1093/schbul/sbn183

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  18 in total

1.  Glucose abnormalities in the siblings of people with schizophrenia.

Authors:  Emilio Fernandez-Egea; Miguel Bernardo; Eduard Parellada; Azucena Justicia; Clemente Garcia-Rizo; Enric Esmatjes; Ignacio Conget; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2008-06-02       Impact factor: 4.939

2.  Family history of type 2 diabetes in schizophrenic patients.

Authors:  S Mukherjee; D B Schnur; R Reddy
Journal:  Lancet       Date:  1989-03-04       Impact factor: 79.321

3.  An abbreviated review of immune abnormalities in schizophrenia.

Authors:  M H Rapaport; K K Delrahim
Journal:  CNS Spectr       Date:  2001-05       Impact factor: 3.790

4.  Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.

Authors:  M H Rapaport; J B Lohr
Journal:  Acta Psychiatr Scand       Date:  1994-11       Impact factor: 6.392

Review 5.  Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia?

Authors:  Michael T Compton; Elaine F Walker
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

6.  Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.

Authors:  Emilio Fernandez-Egea; Miguel Bernardo; Thomas Donner; Ignacio Conget; Eduard Parellada; Azucena Justicia; Enric Esmatjes; Clemente Garcia-Rizo; Brian Kirkpatrick
Journal:  Br J Psychiatry       Date:  2009-05       Impact factor: 9.319

7.  Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Authors:  Dwight Dickinson; Philip D Harvey
Journal:  Schizophr Bull       Date:  2008-08-09       Impact factor: 9.306

Review 8.  Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology.

Authors:  Peter F Whitty; Olabisi Owoeye; John L Waddington
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

9.  Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.

Authors:  Martina C M Ryan; Patrick Collins; Jogin H Thakore
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

10.  Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: effects of antipsychotic drugs.

Authors:  Benedicto Crespo-Facorro; Eugenio Carrasco-Marín; Rocío Pérez-Iglesias; José María Pelayo-Terán; Lorena Fernandez-Prieto; Francisco Leyva-Cobián; José Luis Vázquez-Barquero
Journal:  Psychiatry Res       Date:  2008-02-19       Impact factor: 3.222
View more
  17 in total

1.  Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders.

Authors:  Suraj Sarvode Mothi; Neeraj Tandon; Jaya Padmanabhan; Ian T Mathew; Brett Clementz; Carol Tamminga; Godfrey Pearlson; John Sweeney; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2015-04-19       Impact factor: 4.939

2.  Somatic diseases and conditions before the first diagnosis of schizophrenia: a nationwide population-based cohort study in more than 900 000 individuals.

Authors:  Holger J Sørensen; Philip R Nielsen; Michael E Benros; Carsten B Pedersen; Preben B Mortensen
Journal:  Schizophr Bull       Date:  2014-07-25       Impact factor: 9.306

Review 3.  Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.

Authors:  Matcheri S Keshavan; Henry A Nasrallah; Rajiv Tandon
Journal:  Schizophr Res       Date:  2011-02-12       Impact factor: 4.939

4.  Physical comorbidity in mental illness in paediatric population: need for an integrated health care approach to paediatrics and child psychiatry.

Authors:  Celso Arango
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-08       Impact factor: 4.785

Review 5.  Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models.

Authors:  Chi-Ying Lin; Akira Sawa; Hanna Jaaro-Peled
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

6.  Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia.

Authors:  Gustavo Pacheco-López; Sandra Giovanoli; Wolfgang Langhans; Urs Meyer
Journal:  Schizophr Bull       Date:  2011-12-19       Impact factor: 9.306

7.  Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey.

Authors:  Carmen Moreno; Roberto Nuevo; Somnath Chatterji; Emese Verdes; Celso Arango; José Luis Ayuso-Mateos
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 8.  Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage.

Authors:  Peter Kochunov; L Elliot Hong
Journal:  Schizophr Bull       Date:  2014-05-27       Impact factor: 9.306

9.  A Network of Psychopathological, Cognitive, and Motor Symptoms in Schizophrenia Spectrum Disorders.

Authors:  Bernardo Melo Moura; Geeske van Rooijen; Frederike Schirmbeck; Hanneke Wigman; Luís Madeira; Peter van Harten; Jim van Os; P Roberto Bakker; Machteld Marcelis
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

10.  Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study.

Authors:  Borja García-Bueno; Miquel Bioque; Karina S MacDowell; Javier Santabárbara; Mónica Martínez-Cengotitabengoa; Carmen Moreno; Pilar A Sáiz; Esther Berrocoso; Patricia Gassó; M Fe Barcones; Ana González-Pinto; Mara Parellada; Julio Bobes; Juan A Micó; Miguel Bernardo; Juan C Leza
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.